Venning Advisors Launches New Life Sciences Division to Support Growing Industry Needs
Boston, MA – April 2, 2025 – Venning Advisors, a leading accounting and advisory firm, is proud to announce the launch of its new Life Sciences Division, Venning Life Sciences, dedicated to serving the unique financial and regulatory needs of privately-held and publicly-traded life sciences companies. With this strategic expansion, Venning Life Sciences (VLS) aims to provide tailored solutions that empower biotech, pharmaceutical, and medical device companies to navigate the complexities of the industry.
“The life sciences sector is evolving rapidly, and businesses operating in this space require specialized financial expertise to support their growth and innovation. We will be partnering with founders and executives to provide a bespoke and permanent best-in-class finance and accounting function in a resource-efficient manner,” said Pavan Satyaketu, Senior Managing Director at VLS. “By launching this new division, we are expanding our capabilities to better serve our clients, offering deep industry knowledge and cutting-edge solutions that address the challenges and opportunities they face.”
VLS provides a comprehensive suite of services throughout a company’s lifecycle from privately-held to publicly-traded, including:
Accounting Set Up and Standardization
Finance and Accounting Execution
Financial Planning and Analysis
Technical Accounting and SEC Reporting, including IPO/Merger Readiness
In addition, the VLS team offers a Financial & Business Diagnostic Review aimed to examine People, Process and Technology to uncover misalignments, inefficiencies and opportunities for impactful change. With a team of experienced professionals specialized in the life sciences sector, VLS is committed to supporting businesses at every stage of their development—from startups with early-stage funding to established enterprises navigating regulatory complexities.
“We understand the challenges life sciences companies face, from securing funding and managing R&D costs to navigating ever-changing regulatory landscapes, and ultimately accessing the capital markets to bring innovative life changing products to market,” added Satyaketu. “Our goal is to be a trusted partner to our clients, providing the insights and strategies needed to drive success in this competitive industry.”
The launch of VLS reinforces Venning’s commitment to excellence in accounting and advisory services. For more information about how VLS can support your life sciences business, please visit www.venningls.com.
About Venning Life Sciences
VLS is a next generation finance and accounting firm co-founded by Venning Advisors and Locust Walk, a global life science investment bank. VLS partners with life science founders and executives throughout a company’s lifecycle to provide a customized and permanent best in class finance and accounting function in a resource-efficient manner. Through the firm’s extensive life science experience, process optimization, and technology stack, VLS maintains a standardized, efficient, and high quality finance and accounting team that grows with each company’s needs.